Joint Corp (JYNT) Has Fallen 10% in Last One Year, Underperforms Market

If you are looking for the best ideas for your portfolio you may want to consider some of Artko Capital’s top stock picks. Artko Capital, an investment management firm, is bearish on Joint Corp (NASDAQ:JYNT) stock. In its Q2 2019 investor letter – you can download a copy here – the firm discussed its investment thesis on Joint Corp (NASDAQ:JYNT) stock. Joint Corp (NASDAQ:JYNT) is a franchisor of chiropractic clinics that operates on a non-insurance, cash-based model.

On July 22, 2019, Artko Capital had released its Q2 2019 investor letter. The investment firm said that it exited from Joint Corp (NASDAQ:JYNT) stock in Q2 2019. Joint Corp (NASDAQ:JYNT) stock has posted a return of -10.0% in the trailing one year period, underperforming the S&P 500 Index which returned 12.6% in the same period. This suggests that the investment firm was right in its decision. On a year-to-date basis, Joint Corp (NASDAQ:JYNT) stock has risen by 8.4%.

In Q2 2019 investor letter, Artko Capital said the fund posted a return of 15.1% in the second quarter of 2019, outperforming fund’s benchmark the S&P 500 Index which returned 4.3% in the same period. Let’s take a look at comments made by Artko Capital about Joint Corp (NASDAQ:JYNT) stock in the Q2 2019 investor letter.

“Joint Chiropractic (JYNT) – We have sold the remaining 6% Core Portfolio position in Joint Chiropractic at $17.50-$18.50 price levels, resulting in a 200%+ return on this investment. We are still big fans of the business model and the CEO; however, we felt that the price has gotten ahead of its fundamentals while an increased risk of potential copycat competition modeling on the success of the Joint’s chiropractic subscription service model was not reflected in the stock price. We will continue to follow the company closely and hopefully be able to invest again at much better prices relative to fundamentals.”

Doctor Specialties with Best Lifestyle

Minerva Studio/

In Q1 2020, the number of bullish hedge fund positions on Joint Corp (NASDAQ:JYNT) stock remained unchanged from the previous quarter (see the chart here). Our calculations showed that Joint Corp (NASDAQ:JYNT) isn’t ranked among the 30 most popular stocks among hedge funds.

The top 10 stocks among hedge funds returned 185% since the end of 2014 and outperformed the S&P 500 Index ETFs by more than 109 percentage points. We know it sounds unbelievable. You have been dismissing our articles about top hedge fund stocks mostly because you were fed biased information by other media outlets about hedge funds’ poor performance. You could have doubled the size of your nest egg by investing in the top hedge fund stocks instead of dumb S&P 500 ETFs. Below you can watch our video about the top 5 hedge fund stocks right now. All of these stocks had positive returns in 2020.

Video: Top 5 Stocks Among Hedge Funds

At Insider Monkey we leave no stone unturned when looking for the next great investment idea. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. We go through lists like the 10 most profitable companies in the world to pick the best large-cap stocks to buy. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. You can subscribe to our free enewsletter below to receive our stories in your inbox:

Disclosure: None. This article is originally published at Insider Monkey.